Triglycerides and alanine aminotransferase as screening markers for suspected fatty liver disease in obese children and adolescents

Hormone Research

Volumn 71, Issue 2, 2009, Pages 83-88

  Oliveira, Ana M ^a,b,e   Oliveira, Nelson ^b   Reis, Jussara C ^c   Santos, Marcos V ^b   Silva, Agnaluce M ^d   Adan, Luis ^a  

^a FEDERAL UNIVERSITY OF BAHIA   (Brazil)

^b DEPARTAMENTO DE CIÊNCIAS BIOLÓGICAS   (Brazil)

^c Cleriston Andrade General Hospital   (Brazil)

^d Clinical Pathology Laboratory   (Brazil)

^e NONE   (Brazil)

Author keywords

Metabolic syndrome; Obesity; Pediatrics; Screening procedures; Suspected fatty liver disease

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; BIOLOGICAL MARKER; FERRITIN; GAMMA GLUTAMYLTRANSFERASE; GLUCOSE; HIGH DENSITY LIPOPROTEIN; INSULIN; IRON; TRANSFERRIN; TRIACYLGLYCEROL;

ARTICLE; BLOOD SAMPLING; BODY MASS; CHILD; CLASSIFICATION; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DISEASE ASSOCIATION; ECHOGRAPHY; ENZYME BLOOD LEVEL; FATTY LIVER; FEMALE; FERRITIN BLOOD LEVEL; GROUPS BY AGE; HOMEOSTASIS; HUMAN; IRON BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; OBESITY; ORAL GLUCOSE TOLERANCE TEST; PRIORITY JOURNAL; SCREENING; SEROLOGY; SEX DIFFERENCE; TRANSFERRIN BLOOD LEVEL; WAIST CIRCUMFERENCE; WEIGHT;

ADOLESCENT; ALANINE TRANSAMINASE; BIOLOGICAL MARKERS; BRAZIL; CHILD; FATTY LIVER; FEMALE; HUMANS; MALE; MASS SCREENING; METABOLIC SYNDROME X; OBESITY; PREDICTIVE VALUE OF TESTS; TRIGLYCERIDES;

EID: 58149171480     PISSN: 03010163     EISSN: None     Source Type: Journal    
DOI: 10.1159/000183896     Document Type: Article

References (29)

1. Hossain P, Kawar B, El Nahas M: Obesity and diabetes in the developing world - a growing challenge. N Engl J Med 2007;356:213-215.
2. Veiga GVV, Cunha AS, Sichieri R: Trends in overweight among adolescents living in the poorest and richest regions of Brazil. Am J Public Health 2004;94:1544-1548.
3. Oliveira AM, Oliveira AC, Almeida MS, Oliveira N, Adan L: Influence of the family nucleus on obesity in children from northeastern Brazil: a cross-sectional study BMC Public Health 2007;7:235.
4. Schwimmer JB, Deutsch R, Kahen T, Lavine JE, Stanley C, Behling C: Prevalence of fatty liver in children and adolescents. Pediatrics 2006;118:1388-1393.
5. Quiros-Tejeira RE, Rivera CA, Ziba TT, Mehta N, Smith CW, Butte NF: Risk for nonalcoholic fatty liver disease in Hispanic youth with BMI ≥ 95th percentile. J Pediatr Gastroenterol Nutr 2007;44:228-236.
6. Lavine JE, Schwimmer JB: Nonalcoholic fatty liver disease in the pediatric population. Clin Liver Dis 2004;8:549-588, viii-ix.
7. Adams LA, Angulo P, Lindor KD: Nonalcoholic fatty liver disease. CMAJ 2005;172:889-905.
8. Angulo P: Nonalcoholic fatty liver disease. N Engl J Med 2002;346:1221-1231.
9. Cali AM, Zern TL, Taksali SE, Oliveira AM, Dufour S, Otvos JD, Caprio S: Diab Care 2007;30:3093-3098.
10. Oliveira AC, Oliveira AM, Almeida MS, Silva AM, Adan L, Ladeia AM: Alanine aminotransferase and high sensitivity C-reactive protein: correlates of cardiovascular risk factors in youth. J Pediatr 2008;152:337-342.
11. Chan DF, Li AM, Chu WC, Chan MH, Wong EM, Liu EK, Chan IH, Yin J, Lam CW, Fok TF, Nelson EA: Hepatic steatosis in obese Chinese children. Int J Obes Relat Metab Disord 2004;28:1257-1263.
12. Burget TS, Taksali SE, Dziura J, Goodman TR, Yeckel CW, Papademetris X, Constable RT, Weiss R, Tamborlane WV, Savoye M, Seyal AA, Caprio S: Alanine aminotransferase levels and fatty liver in childhood obesity: associations with insulin resistance, adiponectin, and visceral fat. J Clin Endocrinol Metab 2006;91:4287-4294.
13. Wieckowska A, Feldstein AE: Nonalcoholic fatty liver disease in the pediatric population: a review. Curr Opin Pediatr 2005;17:636-641.
14. American Diabetes Association: Diagnosis and classification of diabetes mellitus. Diabetes Care 2006;29:S43-S48.
15. Tietz NW, Pruden EL, McPherson RA, Fuhrman SA: Clinical Guide to Laboratory Tests, ed 3. Philadelphia, Saunders, 1995, p 1096.
16. Tominaga K, Kurata JH, Chen YK, Fujimoto E, Miyagawa S, Abe I, Kusano Y: Prevalence of fatty liver in Japanese children and relationship to obesity: an epidemiological ultrasonographic survey. Dig Dis Sci 1995;40:2002-2009.
17. Limanond P, Raman SS, Lassman C, Sayre J, Ghobrial RM, Busuttil RW, Saab S, Lu DSK: Macrovesicular hepatic steatosis in living related liver donors: correlation between CT and histologic findings. Radiology 2004;230:276-280.
18. Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 2001;285:2486-2497.
19. Fernandez JR, Redden DT, Pitrobelli A, Allison DB: Waist circumference percentiles in nationally representative samples of African-American, European-American, and Mexican-American children and adolescents. J Pediatr 2004;145:439-444.
20. III Diretrizes Brasileiras sobre Dislipidemias e Diretriz de Prevenção da Aterosclerose do Departamento de Aterosclerose da Sociedade Brasileira de Cardiologia. Arq Bras Cardiol 2001;77(suppl 3):1-48.
21. Update on the 1987 Task Force Report on High Blood Pressure in Children and Adolescents: A working group report from the National High Blood Pressure Education Program. National High Blood Pressure Education Program Working Group on Hypertension Control in Children and Adolescents. Pediatrics 1996;98:649-658.
22. National Health and Nutrition Examination Survey: Anthropometry Procedures Manual. Available online at: http://www.cdc.gov/nchs/data/nhanes/bm. pdf.2002. Accessed on: Oct, 2005.
23. Keskin M, Kurtolgu S, Kendirci M, Atabek ME, Yazici C: Homeostasis model assessment is more reliable than the fasting glucose/insulin ratio and quantitative insulin sensitivity check index for assessing insulin resistance among obese children and adolescents. Pediatrics 2005;115:500-503.
24. Anderson GF, Chu E: Expanding priorities - confronting chronic disease in countries with low income. N Engl J Med 2007:356:209-211.
25. International Diabetes Federation: The IDF consensus worldwide definition of the metabolic syndrome. 2005. Available on line at: http://www.idf.org. Accessed on 02.08.2005.
26. Schwimmer JB, McGreal N, Deutsch R, Finegold MJ, Lavine JE: Influence of gender, race, and ethnicity on suspected fatty liver in obese adolescents. Pediatrics 2005;115:561-565.
27. Angelico F, Ben MD, Conti R, Francioso S, Feole K, Fiorello S, Cavallo MG, Zalunardo B, Lirussi F, Alessandri C, Violi F: Insulin resistance, the metabolic syndrome, and nonalcoholic fatty liver disease. J Clin Endocrinol Metab 2005;90:1578-1582.
28. Yamada J, Tomiyama H, Yambe M, Koji Y, Motobe K, Shiina K, Yamamoto Y, Yamashina A: Elevated serum levels of alanina aminotransferase and γ-glutamyltransferase are markers of inflammation and oxidative stress independent of the metabolic syndrome. Atherosclerosis 2006;189:198-205.
29. Fraser A, Longnecker MP, Lawlor DA: Prevalence of elevated alanine aminotransferase among US adolescents and associated factors: NHANES 1999-2004. Gastroenterology 2007;133:1814-1820.